Immunic (IMUX) Return on Assets (2014 - 2026)

Immunic (IMUX) has 13 years of Return on Assets data on file, last reported at 0.01% in Q1 2026.

• For the quarter ending Q1 2026, Return on Assets rose 2.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (up 2.0% YoY), and the FY2025 full-year result was 0.07%, down 2.0% from the prior year.
• Return on Assets grew to 0.01% in Q1 2026, from 0.03% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.01% in Q2 2024 to a low of 0.03% in Q1 2025.
• A 5-year average of 0.02% and a median of 0.02% in 2023 frame the typical range for Return on Assets.
• Across the five-year window, Return on Assets slipped 2 bps in 2023 and grew 2 bps in 2026, its largest moves.
• Tracing IMUX's Return on Assets over 5 years: stood at 0.02% in 2022, then declined by 6 bps to 0.02% in 2023, then slipped by 13 bps to 0.02% in 2024, then slumped by 72 bps to 0.03% in 2025, then jumped by 67 bps to 0.01% in 2026.
• Business Quant data shows IMUX's Return on Assets at 0.01% in Q1 2026, 0.03% in Q4 2025, and 0.02% in Q3 2025.